Acamas is a drug-delivery technology company enabling therapeutic medicines to better hit their target.

Welcome

Our experienced team is working across multiple disease areas. Our compounds are in trials with several global organisations and we are targeting our first product launch in 2024.

Presently in stealth mode, we welcome interest from pharmaceutical industry companies and investors working in the area of targeted medicine.

By connecting our drug-targeting vector pharmaceutical customers can improve drug targeting and efficacy, reduce side effects, and extend the useful commercial life of their patented, approved drugs.

Want to know more?